Radiation therapy clinic software provider RaySearch Laboratories posted increased net sales of 331.7 million Swedish krona ($34.3 million U.S.) for the first quarter at an operating profit of 74.8 million Swedish krona ($7.7 million).
For the period (end-March 31), the Stockholm, Sweden-based company posted a profit after tax of 56.8 million Swedish krona ($5.9 million), an increase of 55% over the same period last year.
For the three months, RaySearch reported order intake valued at 409.6 million Swedish krona ($42.3 million), a 72% increase over the same period in 2024.
In its interim report, RaySearch also highlighted significant events during the period. They include the following:
- The number of radiation clinics worldwide that have chosen RayStation now exceeds 1,100.
- The first order was made for DrugLog from Children's Memorial Health Institute in Poland.
- A new deal for RayStation was made at the Chinese carbon ion center Heyou Hospital. The firm valued the deal at 77 million Swedish krona ($8 million U.S.), adding that approximately 26 million Swedish krona ($2.7 million U.S.) has been recognized in the first quarter.
The company noted that CEO and board member Johan Löf sold 2 million B-shares in RaySearch Laboratories AB (publ), corresponding to 5.8% of the share capital. The sale was carried out through the conversion of 2 million A-shares to B-shares.
